14 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 15.7% per year over the past 5 years.
Operating margin has contracted, at -27.8% in the latest year.
Financial health
Total debt ($25M) exceeds cash ($3M); net debt is $23M.
Total debt has grown faster than revenue (20.6% vs -15.7% per year).
Operating income covered interest expense -1.4× in the latest year, down from 2.6× 5 years ago.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$30M
-$12M
66.8%
-27.8%
—
$25M
$3M
2024
$35M
$2M
67.9%
16.7%
—
$19M
$687920
2023
$43M
$6M
75.0%
25.3%
—
$17M
$632534
2019
—
-$9M
—
—
—
—
$1M
2018
$34M
-$6M
67.4%
-14.5%
$1M
—
$459736
2017
$36M
$499568
72.4%
5.1%
-$984091
—
$2M
2016
$35M
-$796161
70.7%
8.4%
$6M
—
$3M
2015
$13M
-$8M
60.6%
3.6%
-$652149
—
$4M
2014
$9158
-$960092
38.7%
-10461.8%
—
—
$338
2014
—
-$77336
—
—
—
—
$2660
2013
—
-$56659
—
—
—
—
—
2013
—
-$23201
—
—
—
—
$33908
2013
—
-$36656
—
—
—
—
—
2012
—
-$16200
—
—
—
—
$4000
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$5M
-$3M
72.3%
-10.3%
—
$25M
$292115
Dec '25
$6M
-$15M
36.6%
-219.5%
—
$25M
$3M
Sep '25
$8M
$125327
70.9%
16.0%
—
$25M
$1M
Jun '25
$8M
$1M
76.7%
20.0%
—
$27M
$1M
Mar '25
$8M
$876264
75.4%
23.8%
—
$16M
$177882
Dec '24
$10M
$105667
63.3%
13.2%
—
$19M
$687920
Sep '24
$7M
$783593
67.2%
14.7%
—
—
$259375
Jun '24
$8M
$655186
69.5%
19.7%
—
—
—
Mar '24
$9M
$580530
72.0%
19.2%
—
—
—
Dec '23
$13M
$3M
82.3%
33.5%
—
$17M
$632534
Sep '23
$11M
$1M
72.0%
19.9%
—
—
—
Jun '23
—
$2M
—
—
—
—
—
Mar '23
—
$328428
—
—
—
—
—
Mar '20
—
$262303
—
—
—
—
$314933
Dec '19
—
-$11M
—
—
—
—
$1M
Sep '19
—
$107864
—
—
—
—
$1M
Jun '19
—
$318462
—
—
—
—
$1M
Mar '19
—
$1M
—
—
—
—
$688836
Dec '18
$5M
-$6M
51.3%
-113.1%
-$739133
—
$459736
Sep '18
$9M
$345590
68.0%
7.0%
$1M
—
$2M
Valuation over time
How the market has priced SNYR against its own fundamentals since 2024-10 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 16.2× (Oct '24) to 15.2× (Nov '25).
The price-to-sales ratio has fallen from 2.4× (Oct '24) to 0.1× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is SNYR growing its revenue and profit?
Over the past 5 years, Synergy CHC Corp.'s revenue has declined 15.7% per year. These are computed facts, not advice.
How much debt does SNYR have?
As of FY2025, Synergy CHC Corp. reported $25M of total debt against $3M of cash; operating income covered interest expense -1.4×.
What is SNYR's profit margin?
In FY2025, gross margin was 66.8%, operating margin -27.8%, and net margin -40.6%.
What is SNYR's P/E ratio?
As of Jun '26, Synergy CHC Corp. traded at a price-to-earnings ratio of about 15.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.